Short interest in Quantum BioPharma Ltd (NASDAQ:QNTM) decreased during the last reporting period, falling from 354.44K to 111.77K. This put 6.11% of the company's publicly available shares short.

Quantum BioPharma (NASDAQ: QNTM) has appointed Kevin Malone as an advisor to its Board of Directors. A seasoned financial advisor with over 40 years ...

Quantum BioPharma (NASDAQ: QNTM) has appointed Kevin Malone as an advisor to its Board of Directors. A seasoned financial advisor with over 40 years ...

Mr. Malone is a 2nd generation financial advisor with over 40 years of family experience in wealth management. This combined with his deep entrepreneurial background he launched Malone Wealth in 2021.

Quantum BioPharma announces the appointment of Kevin Malone as an advisor to the Board of Directors. Stay Ahead of the Market: Discover ...

Toronto, Ontario--(Newsfile Corp. - April 18, 2025) - Quantum BioPharma Ltd. (QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Once incredibly popular in the sneakerhead community, brand-new pairs of Adidas Yeezy QNTM Basketball Shoes are on sale now at Shoebacca for as low as $70. The list price of the sneakers is $250 ...

Toronto, Ontario--(Newsfile Corp. - April 18, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the ...

Awards in favour of Quantum BioPharma Totalling $180,000 upheld and is now dueTORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream ...